MX9203021A - DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. - Google Patents

DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.

Info

Publication number
MX9203021A
MX9203021A MX9203021A MX9203021A MX9203021A MX 9203021 A MX9203021 A MX 9203021A MX 9203021 A MX9203021 A MX 9203021A MX 9203021 A MX9203021 A MX 9203021A MX 9203021 A MX9203021 A MX 9203021A
Authority
MX
Mexico
Prior art keywords
carbostirile
derivatives
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
MX9203021A
Other languages
Spanish (es)
Inventor
Minoru Uchida
Makoto Komatsu
Kazuyuki Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX9203021A publication Critical patent/MX9203021A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9203021A 1982-07-05 1992-06-19 DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. MX9203021A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57117311A JPS597168A (en) 1982-07-05 1982-07-05 Carbostyryl derivative

Publications (1)

Publication Number Publication Date
MX9203021A true MX9203021A (en) 1992-07-01

Family

ID=14708605

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203021A MX9203021A (en) 1982-07-05 1992-06-19 DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.

Country Status (5)

Country Link
JP (1) JPS597168A (en)
KR (1) KR900006401B1 (en)
BE (1) BE897208A (en)
MX (1) MX9203021A (en)
ZA (1) ZA834901B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308258A (en) * 1989-04-27 1989-12-12 Otsuka Pharmaceut Co Ltd Carbostyril derivative
KR0180248B1 (en) * 1991-06-07 1999-03-20 오오쓰까 아끼히꼬 Antidiabetic
JP2872546B2 (en) * 1992-11-26 1999-03-17 大塚製薬株式会社 Intestinal mucosal damage protective agent
TWI340650B (en) 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
WO2013108644A1 (en) * 2012-01-20 2013-07-25 京都府公立大学法人 Rebamipide therapeutic agent for allergic conjunctivitis
CN103113294B (en) * 2013-03-11 2016-04-27 浙江远力健药业有限责任公司 The synthetic method of rebamipide
KR101965804B1 (en) * 2016-09-09 2019-04-05 김영훈 Microbe Fermenting Agent for Improving Properties of Pill & Manufacturing Method of Pill for Absorption after Digestion Using the Same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065572A (en) * 1976-02-13 1977-12-27 Merck & Co., Inc. Amino acids and esters thereof useful as antihypertensive agents

Also Published As

Publication number Publication date
ZA834901B (en) 1984-03-28
BE897208A (en) 1984-01-04
KR900006401B1 (en) 1990-08-30
JPS6335623B2 (en) 1988-07-15
JPS597168A (en) 1984-01-14
KR840005427A (en) 1984-11-12

Similar Documents

Publication Publication Date Title
MX9203226A (en) DERIVATIVES OF PHENETHANOLAMINE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9203040A (en) DERIVATIVES OF QUINONA AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9202910A (en) NEW DERIVATIVES OF DIHYDROPIRIDINE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
MX9202934A (en) DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9203380A (en) DERIVATIVES OF CARBAZOLIL- (4) -OXI-PROPANOLAMINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9203027A (en) HETEROCICLIC DERIVATIVES OF ACILAMINOTIAZOLES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9202623A (en) INDOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9203126A (en) DERIVATIVES OF SULFONILUREA AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9202851A (en) PHOSPHATE DERIVATIVES OF 4-DESMETILEPIPODOFILOTOXINA GLUCOSIDES AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM.
MX9203368A (en) LIPOPHILIC MURAMILPEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR1100036A (en) Pharmaceutical composition and composition
MX9203177A (en) DERIVATIVES OF 1-FLUOROPHENYLBUTYL-4- (2-PIRIMIDINYL) PIPERAZINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9203363A (en) NEW DERIVATIVES OF 3-AMINOPROPANSULFONICO ACID AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9203114A (en) NEW MORFOLINO DERIVATIVES OF DAUNORUBICIN AND DOXORUBICIN AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR231972A1 (en) DERIVATIVES OF N- (ARILOIL OR HETEROARILOIL) -N-PHENYL-UREA, PESTICIDE COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES
MX9203108A (en) DI-T-BUTYLPHENOL COMPOUNDS AND COMPOSITIONS CONTAINING THEM.
MX9204563A (en) NEW DERIVATIVES OF (2-ALQUIL-3-PIRIDIL) -METILPIPERAZINA AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
MX9202848A (en) DESIGNATED ANTIBIOTIC COMPLEXES BBM-2478A AND BBM-2478BY PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR231443A1 (en) ISOXAZOLYLBENZAMIDES COMPOUNDS AND COMPOSITION WHICH INCLUDES THEM
MX9202935A (en) DERIVATIVES OF 2,3-DIHYDRO-1H-INDENO AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9203639A (en) 3-PHENOXI-1-AZETIDINCARBOXAMIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9203628A (en) FLOWERED BENCILTRIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9202763A (en) NEW DERIVATIVES OF 2- (1-PIPERAZINIL) -4-FENIL-CICLOALCANOPIRIDINA AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
AR240802A1 (en) DERIVATIVES OF 3-PHENYL-4-CYANOPYROL, PROCEDURE FOR ITS PREPARATION AND MICROBICIDE COMPOSITIONS THAT CONTAIN THEM
MX9203613A (en) DERIVATIVES OF ADENOSINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.